Viewing Study NCT03136861

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:10 PM
Ignite Modification Date: 2026-02-08 @ 2:25 PM
Study NCT ID: NCT03136861
Status: COMPLETED
Last Update Posted: 2021-09-05
First Post: 2017-04-28
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: SKIPPAIN - Speed of Onset of SecuKinumab-Induced Relief From Pain in Patients With AxIal SpoNdyloarthritis
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Spondyloarthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None axial spondyloarthritis View
None ankylosing spondylitis View
None non-radiographic axial spondyloarthritis View
None inflammatory back pain View
None spinal pain View
None secukinumab View
None AIN457 View